Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change

Typeset version

 

TY  - JOUR
  - Norberg, S,O'Connor, PM,Stanton, C,Ross, RP,Hill, C,Fitzgerald, GF,Cotter, PD
  - 2012
  - January
  - Applied and Environmental Microbiology
  - Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change
  - Validated
  - ()
  - ENTEROBACTER-SAKAZAKII LISTERIA-MONOCYTOGENES LANTIBIOTIC LACTICIN-3147 ANTIBACTERIAL NISIN HYDROPHOBICITY MECHANISM CHARGE MILK
  - 78
  - 2353
  - 2358
  - Caseicins A and B are low-molecular-weight antimicrobial peptides which are released by proteolytic digestion of sodium caseinate. Caseicin A (IKHQGLPQE) is a nine-amino-acid cationic peptide, and caseicin B (VLNENLLR) is a neutral eight-amino-acid peptide; both have previously been shown to exhibit antibacterial activity against a number of pathogens, including Cronobacter sakazakii. Previously, four variants of each caseicin which differed subtly from their natural counterparts were generated by peptide synthesis. Antimicrobial activity assays revealed that the importance of a number of the residues within the peptides was dependent on the strain being targeted. In this study, this engineering-based approach was expanded through the creation of a larger collection of 26 peptides which are altered in a variety of ways. The investigation highlights the generally greater tolerance of caseicin B to change, the fact that changes have a more detrimental impact on anti-Gram-negative activity, and the surprising number of variants which exhibit enhanced activity against Staphylococcus aureus.
  - DOI 10.1128/AEM.07312-11
DA  - 2012/01
ER  - 
@article{V160748038,
   = {Norberg,  S and O'Connor,  PM and Stanton,  C and Ross,  RP and Hill,  C and Fitzgerald,  GF and Cotter,  PD },
   = {2012},
   = {January},
   = {Applied and Environmental Microbiology},
   = {Extensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change},
   = {Validated},
   = {()},
   = {ENTEROBACTER-SAKAZAKII LISTERIA-MONOCYTOGENES LANTIBIOTIC LACTICIN-3147 ANTIBACTERIAL NISIN HYDROPHOBICITY MECHANISM CHARGE MILK},
   = {78},
  pages = {2353--2358},
   = {{Caseicins A and B are low-molecular-weight antimicrobial peptides which are released by proteolytic digestion of sodium caseinate. Caseicin A (IKHQGLPQE) is a nine-amino-acid cationic peptide, and caseicin B (VLNENLLR) is a neutral eight-amino-acid peptide; both have previously been shown to exhibit antibacterial activity against a number of pathogens, including Cronobacter sakazakii. Previously, four variants of each caseicin which differed subtly from their natural counterparts were generated by peptide synthesis. Antimicrobial activity assays revealed that the importance of a number of the residues within the peptides was dependent on the strain being targeted. In this study, this engineering-based approach was expanded through the creation of a larger collection of 26 peptides which are altered in a variety of ways. The investigation highlights the generally greater tolerance of caseicin B to change, the fact that changes have a more detrimental impact on anti-Gram-negative activity, and the surprising number of variants which exhibit enhanced activity against Staphylococcus aureus.}},
   = {DOI 10.1128/AEM.07312-11},
  source = {IRIS}
}
AUTHORSNorberg, S,O'Connor, PM,Stanton, C,Ross, RP,Hill, C,Fitzgerald, GF,Cotter, PD
YEAR2012
MONTHJanuary
JOURNAL_CODEApplied and Environmental Microbiology
TITLEExtensive Manipulation of Caseicins A and B Highlights the Tolerance of These Antimicrobial Peptides to Change
STATUSValidated
TIMES_CITED()
SEARCH_KEYWORDENTEROBACTER-SAKAZAKII LISTERIA-MONOCYTOGENES LANTIBIOTIC LACTICIN-3147 ANTIBACTERIAL NISIN HYDROPHOBICITY MECHANISM CHARGE MILK
VOLUME78
ISSUE
START_PAGE2353
END_PAGE2358
ABSTRACTCaseicins A and B are low-molecular-weight antimicrobial peptides which are released by proteolytic digestion of sodium caseinate. Caseicin A (IKHQGLPQE) is a nine-amino-acid cationic peptide, and caseicin B (VLNENLLR) is a neutral eight-amino-acid peptide; both have previously been shown to exhibit antibacterial activity against a number of pathogens, including Cronobacter sakazakii. Previously, four variants of each caseicin which differed subtly from their natural counterparts were generated by peptide synthesis. Antimicrobial activity assays revealed that the importance of a number of the residues within the peptides was dependent on the strain being targeted. In this study, this engineering-based approach was expanded through the creation of a larger collection of 26 peptides which are altered in a variety of ways. The investigation highlights the generally greater tolerance of caseicin B to change, the fact that changes have a more detrimental impact on anti-Gram-negative activity, and the surprising number of variants which exhibit enhanced activity against Staphylococcus aureus.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URL
DOI_LINKDOI 10.1128/AEM.07312-11
FUNDING_BODY
GRANT_DETAILS